[72] One survey of adults that had been treated with replacement cadaver GH (which has not been used anywhere in the world since 1985) during childhood showed a mildly increased incidence of colon cancer and prostate cancer, but linkage with the GH treatment was not established
Some patients experience weight loss within their first week of treatment
PET with [18F]FDG for cerebral metabolism, or [18F]AV-45 for amyloid load in AD models
Metabolically Sensitive Patients Patients with existing insulin resistance, prediabetes, or a history of severe gastrointestinal distress often struggle with GLP-1 medications
(Innopeptides) Long-term storage, delivery (penetration into tissues, safety of cell-penetrating segments) are still being worked out
These mechanisms address the underlying tissue dysfunction rather than masking symptoms